CDH1 and gastric cancer: By following guideline criteria for genetic testing, the detection rate of CDH1 pathogenic variants is 30–50% in selected patients from populations with low GC incidence, while it drops down to 10–20% in countries (like Italy) with a medium-high incidence of GC [14,15].